Latest funding for NHMRC and MRFF initiatives announced
Congratulations to our staff and partners across the School of Biomedical Sciences for their recent successes in the NHMRC and MRFF funding rounds.
Coronavirus Research Response
Professor Stephen Kent Department of Microbiology and Immunology and Peter Doherty Institute
Chimeric next generation COVID vaccines
Professor Joseph Torresi Department of Microbiology and Immunology and Peter Doherty Institute
AdaptiVax-CoV: A Novel Self-adjuvanting SARS-CoV2 VLP Vaccine to Produce Humoral and T cell responses to S, E and M proteins
Prof Dale Godfrey Department of Microbiology and Immunology and Peter Doherty Institute
A safe, effective, and rapidly tuneable SARS-CoV-2 vaccine
Prof Katherine Kedzierska Department of Microbiology and Immunology and Peter Doherty Institute
Defining immune responses in COVID-19 to understand susceptibility and target treatments
Emerging Priorities and Consumer Driven Research Initiative
Dr Alexander Barrow Department of Microbiology and Immunology and Peter Doherty Institute
Role of the NKp44-PDGF-DD axis in Glioblastoma
Genomics Health Futures Mission
Prof Benjamin Howden Department of Microbiology and Immunology and Peter Doherty Institute
Precision Public Health in Australia through Integrated Pathogen Genomics
Prof Deborah Williamson Department of Microbiology and Immunology and Peter Doherty Institute
META-GP: Delivering a Clinical Metagenomics Platform for Australia
Global Health Initiative
Prof Lachlan Coin Department of Microbiology and Immunology and Peter Doherty Institute
Rapid characterisation of Mycobacterium tuberculosis from sputum
Stem Cell Therapies Mission
Dr Lincon Stamp Florey Institute and Department of Anatomy and Physiology
Stem cell therapies for digestive disease
Professor Alice Pebay Department of Surgery, Department of Anatomy and Physiology
Novel SMART AAV vectors for gene therapy for Friedreich’s Ataxia (led by University of Wollongong)